Vaccination with multiple peptides derived from novel cancer‐testis antigens can induce specific T‐cell responses and clinical responses in advanced esophageal cancerKoji Kono, Hideki Fujii, Yusuke Nakamura et al.|Cancer Science|2009Cited by 136
Identification of human leukocyte antigen‐A24‐restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapyTakako Suda, Hideaki Tahara, Yusuke Nakamura et al.|Cancer Science|2007Cited by 120
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancerMotoki Miyazawa, Hiroki Yamaue, R. Ohsawa et al.|Cancer Science|2009Cited by 117
HLA‐A2‐restricted CTL epitopes of a novel lung cancer‐associated cancer testis antigen, cell division cycle associated 1, can induce tumor‐reactive CTLMichiko Harao, Yasuharu Nishimura, Shuichi Nakatsuru et al.|International Journal of Cancer|2008Cited by 92
Detection of novel cancer‐testis antigen‐specific T‐cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinomaYoshiki Mizukami, Hideki Fujii, Koji Kono et al.|Cancer Science|2008Cited by 77